Therapy Against Ischemic Injury

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|25|4597-4621

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.25, 2013-08, pp. : 4597-4621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury

By  

Current Medicinal Chemistry, Vol. 16, Iss. 34, 2009-12 ,pp. : 4502-4510

Bentham Science Publishers

Access to resources Recommend Favorite

Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation

By Calapai G.   Marciano M.C.   Corica F.   Allegra A.   Parisi A.   Frisina N.   Caputi A.P.   Buemi M.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 349-356

Elsevier

Access to resources Recommend Favorite

Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-01 ,pp. : 167-175

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy Against Reperfusion-induced Microvascular Injury

By  

Current Pharmaceutical Design, Vol. 19, Iss. 25, 2013-08 ,pp. : 4586-4596

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuroprotective Mechanism of Erythropoietin-TAT Fusion Protein Against Neurodegeneration from Ischemic Brain Injury

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1465-1474

Bentham Science Publishers

Access to resources Recommend Favorite